Brewer Science Library Phone: (608) 647-6513 r
The following article is
reprinted from New Horizons newsletter,
published by the Brewer Science Library. Single
copies of the article may be printed for the
reader's personal research and study. Reproduction
in any other manner, format or location is
Brewer Science Library
Phone: (608) 647-6513
The following article is reprinted from New Horizons newsletter, published by the Brewer Science Library. Single copies of the article may be printed for the reader's personal research and study. Reproduction in any other manner, format or location is expressly prohibited.
(c) 1999 Brewer Science Library, All rights reserved
Excerpted from New Horizons, Winter 1999
There are many factors to look at in assessing how far an individual might progress on Dr. Nieper's protocol. Over the years in his lectures and writings he mentioned a few, and others can be concluded from patient experiences.
People with very small and inaccessible blood vessels have a much harder time staying on this protocol. They need a great deal of motivation to do all the preparatory procedures such as hot packs over their arm veins in order to successfully continue the program. Many of them opt for a portacath, which solves the delivery problem for them. Dr. Nieper was not in favor of portacaths because of the increased risk of life-threatening infection with them. Recovery after one of these infections is often very slow for an MS patient and they could lose what benefits they had gained from the IV Ca EAP treatments.
Willingness to follow the dietary restrictions is another factor that Dr. Nieper stressed. It is so easy for people to put all their emphasis on the IV Calcium EAP and not be attentive to their dietary habits. A poor diet can undermine the protocol. A diet high in sugar, saturated fats and dairy products can stress the body to such a degree that one cannot attain the level of progress desired.
Attentive awareness to the changing condition of one's body and a willingness to respond appropriately to its needs helps the protocol succeed. Resting when one is starting to become tired, instead of overdoing it until one is exhausted is an example of paying attention to the needs of the body.
Dr. Nieper also considered it absolutely essential that patients stay away from the electromagnetic fields coming from electrical outlets and electrical appliances. He wanted patients to especially check their bedroom outlets where they usually spend more than one-third of their lives.
Dr. Nieper also felt that one of the reasons some patients were not improving on his therapy was because the individual's residence was located over geopathogenic fields that were affecting their physical well-being.
Consistency in taking the oral supplements that support the IV protocol is another vitally important part of maximizing one's possibility for success.
Although there were variations in the "Nieper treatment" over the years for individual patients, in general it consisted of three Calcium EAP IVs a week, along with two or three capsules of the oral Calcium EAP and the Calcium-Magnesium-Potassium-EAP daily. ***********************
In the year or so before his untimely death, Dr. Nieper had been putting more people on the drip IV Calcium EAP protocol for the first few months on their therapy. The drip IV takes about a half hour to forty minutes and usually 2 vials of Calcium EAP are used along with some other specific substances. For some patients the drip IV is their primary mode of delivery and they maintain their program with it. Dr. Nieper had others do the drip IV for a few months and then had them switch to the direct IV injection. Some people, who did not seem to be benefiting from the IV injections, started improving when they were then switched to the IV drip protocol. (Denise Hasenstab, a nurse with MS herself who is also on the IV drip protocol is willing to answer questions about it:  457-9707.)
Dr. Nieper also put some patients on a new herbal anti-viral, olive leaf extract, if he determined their MS had a significant viral component to it. He still continued to use the liquid mandelonitrile compound as an anti-viral with most of his patients with a viral aspect to their MS.
DISCLAIMER: The information contained on this website has not been evaluated by the Food & Drug Administration. It is not meant to diagnose, treat, cure or prevent any disease. Individuals suffering from any disease or illness should consult with a physician or health care professional. The Brewer Science Library offers Dr. Brewer's writings for information purposes only and will assume no responsibility or liability for the use of any of the information we offer whether written by Dr. Brewer or others.
1998-2006, Brewer Science Library
Problems with this site? Contact the webmaster.